MedPharm inks deal to support global pharmaceutical company with commercial site transfer

The Medical News ·
Health & Medicine United Kingdom

MedPharm, a global leader in topical and transdermal contract drug development and manufacturing, today announced that it has signed a new agreement with a global pharmaceutical company to support the commercial site transfer and commercial manufacturing of their branded specialty topical pharmaceutical product.

Read original article on The Medical News →

Related news